BRRADLACNOR0
BRRADLACNOR0
RAIADROGASILON NM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 37.52B EUR | 29.39B EUR | 41.14B EUR | 41.79B EUR |
Enterprise Value | 44.34B EUR | 37.45B EUR | 49.39B EUR | 50.12B EUR |
Valuation Multiples | ||||
Trailing P/E | 26.82x | 33.08x | 49.1x | 49.58x |
Forward P/E | 18.49x | -- | -- | -- |
Price to Sales | 0.81x | 0.87x | 1.26x | 1.33x |
Price to Book | 5.15x | 4.03x | 5.61x | 5.71x |
EV/Revenue | 0.95x | 1.11x | 1.51x | 1.59x |
EV/EBITDA | 11.49x | 8.69x | 11.92x | 13.04x |
Price to FCF (P/FCF) | 17.2x | 325.61x | -- | -- |
EV/FCF | 20.33x | 414.86x | -- | -- |
FCF Yield | 5.81% | 0.31% | -0.61% | -1.22% |